Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.

Blood cells, molecules & diseases - 1 Jan 2000

El Ghannam Doaa, Taalab Mona M, Ghazy Hayam F, Eneen Asmaa F

Abstract excerpt

Several molecular markers have been described that help to classify patients with acute myeloid leukemia (AML), a heterogeneous hematopoietic tissue neoplasm, into risk groups. We determined the frequency of DNMT3A mutations, their associations with clinical and molecular characteristics and outcome, in primary, cytogenetically-normal AML (CN-AML) and CN-myelodysplastic syndrome (MDS). A total of 63 CN-AML and 16...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Cytogenetic Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA (Cytosine-5-)-Methyltransferases

Share to DNA Methyltransferase 3A

Share to Leukemia, Myeloid, Acute

Share to Mutation Rate

Share to Myelodysplastic Syndromes

Share to Nucleophosmin

Source

Identifiers

PMID: 24512939
DOI: 10.1016/j.bcmd.2014.01.004

Genes

NPM1
FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.PMID 24512939Read ↗

DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.Semantic proximity Read ↗

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.Semantic proximity Read ↗

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.Semantic proximity Read ↗

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML TransformationSemantic proximity Read ↗

Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.Semantic proximity Read ↗

Characteristics of DNMT3A mutations in acute myeloid leukemiaSemantic proximity Read ↗

Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations.Semantic proximity Read ↗

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.Semantic proximity Read ↗

Acute myeloid leukemia with DNMT3A mutations.Semantic proximity Read ↗

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.Semantic proximity Read ↗

Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

DNMT3A-R882: a mutation with many paradoxes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.